| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Why Is Picard Medical Stock Gaining Monday? | 3 | Benzinga.com | ||
| Do | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | 170 | GlobeNewswire (Europe) | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| Mi | Picard Medical reports Q2 results | 2 | Seeking Alpha | ||
| Mi | Picard Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17.08. | Picard Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 31.07. | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | 1 | GlobeNewswire (USA) | ||
| PICARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.07. | Picard Medical, Inc.: Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 | 2 | GlobeNewswire (USA) | ||
| 27.07. | Picard Medical regains NYSE compliance | 2 | Seeking Alpha | ||
| 27.07. | Picard Medical regains compliance with NYSE American listing | 1 | Investing.com | ||
| 27.07. | Picard Medical, Inc.: Picard Medical Receives NYSE American Acceptance of Compliance Plan | 257 | GlobeNewswire (Europe) | TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first... ► Artikel lesen | |
| 22.07. | Picard Medical announces 1-for-50 reverse stock split to maintain NYSE American listing; stock slips | 3 | Seeking Alpha | ||
| 22.07. | Picard Medical approves 1-for-50 reverse stock split | 4 | Investing.com | ||
| 22.07. | Picard Medical, Inc.: Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance | 263 | GlobeNewswire (Europe) | -Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the... ► Artikel lesen | |
| 21.07. | Picard Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 15.07. | Picard Medical's artificial heart platform reviewed in journal | 2 | Investing.com | ||
| 15.07. | Fachzeitschrift beleuchtet Plattform für künstliches Herz von Picard Medical | 2 | Investing.com Deutsch | ||
| 15.07. | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | 149 | GlobeNewswire (Europe) | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| 13.07. | Picard Medical, Inc.: Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 02.07. | Picard Medical, Inc. - 8-K, Current Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 26,880 | +0,90 % | Aktien New York: Chipwerte belasten Nasdaq - US-Pläne gegen Iran bewegen kaum | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA erneut geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen | |
| CERENOME | 2,530 | +1,20 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| ORGANON | 11,745 | -0,42 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,285 | -1,17 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| NANO-X IMAGING | 0,863 | -0,14 % | NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom | Initial three-year term includes minimum annual license commitments
PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. ("Nanox", or the "Company" NASDAQ: NNOX), a leader in innovative medical... ► Artikel lesen | |
| ROCKWELL MEDICAL | 7,970 | +0,89 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 0,970 | -7,59 % | Nuwellis, Inc.: Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical | ||
| INSPIREMD | 0,785 | +8,28 % | InspireMD Targets $9 Million Of Annual Cost Savings As CGuard TCAR Study Reports 100% Acute Device Success | ||
| PROCEPT BIOROBOTICS | 21,590 | +1,60 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,490 | +0,81 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| GLUCOTRACK | 0,337 | +1,38 % | Glucotrack, Inc. - 8-K, Current Report | ||
| OPTIMIZERX | 7,880 | +3,01 % | OptimizeRx Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| OWLET | 5,210 | +2,56 % | Owlet: Hauptversammlung stimmt für Vergütungsplan und wählt Direktoren | ||
| FEMASYS | 2,875 | -3,52 % | Femasys Inc.: Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc | ATLANTA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 0,916 | +1,78 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen |